Mahmoud Aly

Mahmoud Aly

Auto-generated profile, based on publicly available information

Mahmoud Aly

Department of Radiology, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
BKBenjamin Koa
Benjamin Koa
ABAustin J. Borja
Austin J. Borja
MAMahmoud Aly
Mahmoud Aly
SPSayuri Padmanabhan
Sayuri Padmanabhan
JTJoseph Tran
Joseph Tran
MRMona-Elisabeth Revheim
Mona-Elisabeth Revheim
Castleman disease (CD) describes a group of rare hematologic conditions involving lymphadenopathy with characteristic histopathology and a spectrum of clinical abnormalities. CD is divided into localized or unicentric CD (UCD) and multicentric CD (MCD) by imaging. MCD is further divided based on etiological driver into human herpesvirus-8-associated MCD, POEMS-associated MCD, and idiopathic MCD. There is notable heterogeneity across MCD, but increased level of pro-inflammatory cytokines, particularly interleukin-6, is an established disease driver in a portion of patients. FDG-PET/CT can help determine UCD versus MCD, evaluate for neoplastic conditions that can mimic MCD clinico-pathologically, and monitor therapy responses. CD requires more robust characterization, earlier diagnosis, and an accurate tool for both monitoring and treatment response evaluation; FDG-PET/CT is particularly suited for this. Moving forward, future prospective studies should further characterize the use of FDG-PET/CT in CD and specifically explore the utility of global disease assessment and dual time point imaging.Trial registrationClinicalTrials.gov, NCT02817997, Registered 29 June 2016,https://clinicaltrials.gov/ct2/show/NCT02817997